Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Robert C Green, M.D.

Co-Author

This page shows the publications co-authored by Robert Green and Kurt Christensen.
Connection Strength

7.089
  1. A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone. Genet Med. 2018 01; 20(1):132-141.
    View in: PubMed
    Score: 0.738
  2. Assessing the Costs and Cost-Effectiveness of Genomic Sequencing. J Pers Med. 2015 Dec 10; 5(4):470-86.
    View in: PubMed
    Score: 0.660
  3. How could disclosing incidental information from whole-genome sequencing affect patient behavior? Per Med. 2013 Jun; 10(4).
    View in: PubMed
    Score: 0.554
  4. Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease risk. Genet Med. 2011 May; 13(5):409-14.
    View in: PubMed
    Score: 0.480
  5. Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience. Genet Med. 2008 Mar; 10(3):207-14.
    View in: PubMed
    Score: 0.385
  6. Behavioral and psychological impact of genome sequencing: a pilot randomized trial of primary care and cardiology patients. NPJ Genom Med. 2021 Aug 24; 6(1):72.
    View in: PubMed
    Score: 0.245
  7. Primary care providers' responses to unsolicited Lynch syndrome secondary findings of varying clinical significance. Genet Med. 2021 10; 23(10):1977-1983.
    View in: PubMed
    Score: 0.242
  8. Precision Population Medicine in Primary Care: The Sanford Chip Experience. Front Genet. 2021; 12:626845.
    View in: PubMed
    Score: 0.238
  9. Disclosing genetic risk for Alzheimer's dementia to individuals with mild cognitive impairment. Alzheimers Dement (N Y). 2020; 6(1):e12002.
    View in: PubMed
    Score: 0.222
  10. Cost Analyses of Genomic Sequencing: Lessons Learned from the MedSeq Project. Value Health. 2018 09; 21(9):1054-1061.
    View in: PubMed
    Score: 0.199
  11. Short-term costs of integrating whole-genome sequencing into primary care and cardiology settings: a pilot randomized trial. Genet Med. 2018 12; 20(12):1544-1553.
    View in: PubMed
    Score: 0.193
  12. Communication Predictors of Patient and Companion Satisfaction with Alzheimer's Genetic Risk Disclosure. J Health Commun. 2018; 23(8):807-814.
    View in: PubMed
    Score: 0.190
  13. Preferences for the Return of Individual Results From Research on Pediatric Biobank Samples. J Empir Res Hum Res Ethics. 2017 04; 12(2):97-106.
    View in: PubMed
    Score: 0.181
  14. Disclosing genetic risk of Alzheimer's disease to cognitively impaired patients and visit companions: Findings from the REVEAL Study. Patient Educ Couns. 2017 05; 100(5):927-935.
    View in: PubMed
    Score: 0.177
  15. Adopting genetics: motivations and outcomes of personal genomic testing in adult adoptees. Genet Med. 2016 09; 18(9):924-32.
    View in: PubMed
    Score: 0.167
  16. Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial. Ann Intern Med. 2016 Feb 02; 164(3):155-63.
    View in: PubMed
    Score: 0.167
  17. Are physicians prepared for whole genome sequencing? a qualitative analysis. Clin Genet. 2016 Feb; 89(2):228-34.
    View in: PubMed
    Score: 0.160
  18. Associations between self-referral and health behavior responses to genetic risk information. Genome Med. 2015; 7(1):10.
    View in: PubMed
    Score: 0.156
  19. Factors affecting recall of different types of personal genetic information about Alzheimer's disease risk: the REVEAL study. Public Health Genomics. 2015; 18(2):78-86.
    View in: PubMed
    Score: 0.155
  20. A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease. Alzheimers Dement. 2015 Oct; 11(10):1222-30.
    View in: PubMed
    Score: 0.154
  21. Communicating genetic risk information for common disorders in the era of genomic medicine. Annu Rev Genomics Hum Genet. 2013; 14:491-513.
    View in: PubMed
    Score: 0.135
  22. Using Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomics. Clin Genet. 2011 Nov; 80(5):407-14.
    View in: PubMed
    Score: 0.122
  23. Psychosocial Effect of Newborn Genomic Sequencing on Families in the BabySeq Project: A Randomized Clinical Trial. JAMA Pediatr. 2021 Nov 01; 175(11):1132-1141.
    View in: PubMed
    Score: 0.062
  24. Do research participants share genomic screening results with family members? J Genet Couns. 2021 Oct 19.
    View in: PubMed
    Score: 0.062
  25. Effects of participation in a U.S. trial of newborn genomic sequencing on parents at risk for depression. J Genet Couns. 2021 Jul 26.
    View in: PubMed
    Score: 0.061
  26. Universal newborn genetic screening for pediatric cancer predisposition syndromes: model-based insights. Genet Med. 2021 07; 23(7):1366-1371.
    View in: PubMed
    Score: 0.060
  27. Airmen and health-care providers' attitudes toward the use of genomic sequencing in the US Air Force: findings from the MilSeq Project. Genet Med. 2020 12; 22(12):2003-2010.
    View in: PubMed
    Score: 0.057
  28. Returning Results in the Genomic Era: Initial Experiences of the eMERGE Network. J Pers Med. 2020 Apr 27; 10(2).
    View in: PubMed
    Score: 0.056
  29. Quantifying Downstream Healthcare Utilization in Studies of Genomic Testing. Value Health. 2020 05; 23(5):559-565.
    View in: PubMed
    Score: 0.055
  30. Psychological outcomes related to exome and genome sequencing result disclosure: a meta-analysis of seven Clinical Sequencing Exploratory Research (CSER) Consortium studies. Genet Med. 2019 12; 21(12):2781-2790.
    View in: PubMed
    Score: 0.053
  31. Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study. Genet Med. 2019 May; 21(5):1261-1262.
    View in: PubMed
    Score: 0.052
  32. Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study. Genet Med. 2019 05; 21(5):1100-1110.
    View in: PubMed
    Score: 0.050
  33. The BabySeq project: implementing genomic sequencing in newborns. BMC Pediatr. 2018 07 09; 18(1):225.
    View in: PubMed
    Score: 0.049
  34. Enhancing Autonomy in Biobank Decisions: Too Much of a Good Thing? J Empir Res Hum Res Ethics. 2018 04; 13(2):125-138.
    View in: PubMed
    Score: 0.048
  35. Patient understanding of, satisfaction with, and perceived utility of whole-genome sequencing: findings from the MedSeq Project. Genet Med. 2018 09; 20(9):1069-1076.
    View in: PubMed
    Score: 0.048
  36. The impact of genetic counselors' use of facilitative strategies on cognitive and emotional processing of genetic risk disclosure for Alzheimer's disease. Patient Educ Couns. 2018 05; 101(5):817-823.
    View in: PubMed
    Score: 0.047
  37. The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients: A Pilot Randomized Trial. Ann Intern Med. 2017 08 01; 167(3):159-169.
    View in: PubMed
    Score: 0.046
  38. When bins blur: Patient perspectives on categories of results from clinical whole genome sequencing. AJOB Empir Bioeth. 2017 Apr-Jun; 8(2):82-88.
    View in: PubMed
    Score: 0.045
  39. Family health history reporting is sensitive to small changes in wording. Genet Med. 2016 12; 18(12):1308-1311.
    View in: PubMed
    Score: 0.042
  40. Participants and Study Decliners' Perspectives About the Risks of Participating in a Clinical Trial of Whole Genome Sequencing. J Empir Res Hum Res Ethics. 2016 02; 11(1):21-30.
    View in: PubMed
    Score: 0.042
  41. Patients' perceived utility of whole-genome sequencing for their healthcare: findings from the MedSeq project. Per Med. 2016 Jan 01; 13(1):13-20.
    View in: PubMed
    Score: 0.041
  42. Participant Satisfaction With a Preference-Setting Tool for the Return of Individual Research Results in Pediatric Genomic Research. J Empir Res Hum Res Ethics. 2015 Oct; 10(4):414-26.
    View in: PubMed
    Score: 0.041
  43. Disclosing genetic risk for coronary heart disease: effects on perceived personal control and genetic counseling satisfaction. Clin Genet. 2016 Feb; 89(2):251-7.
    View in: PubMed
    Score: 0.039
  44. 'Someday it will be the norm': physician perspectives on the utility of genome sequencing for patient care in the MedSeq Project. Per Med. 2015; 12(1):23-32.
    View in: PubMed
    Score: 0.039
  45. A systematic approach to the reporting of medically relevant findings from whole genome sequencing. BMC Med Genet. 2014 Dec 14; 15:134.
    View in: PubMed
    Score: 0.039
  46. The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine. Trials. 2014 Mar 20; 15:85.
    View in: PubMed
    Score: 0.037
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.